We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MRNA market cap is 11.51B. The company's latest EPS is USD -9.2298 and P/E is -3.28.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.81B | 167M | 241M | 1.86B | 966M |
| Operating Income | 6M | -1.27B | -1.36B | -70M | -1.25B |
| Net Income | 217M | -1.18B | -1.28B | 13M | -1.12B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 803.4M | 18.47B | 19.26B | 6.85B | 3.24B |
| Operating Income | -763.14M | 13.3B | 9.42B | -4.24B | -3.95B |
| Net Income | -747.1M | 12.2B | 8.36B | -4.71B | -3.56B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.43B | 16.73B | 15.68B | 15.8B | 14.14B |
| Total Liabilities | 4.57B | 3.91B | 3.97B | 3.88B | 3.24B |
| Total Equity | 13.85B | 12.82B | 11.71B | 11.93B | 10.9B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.34B | 24.67B | 25.86B | 18.43B | 14.14B |
| Total Liabilities | 4.78B | 10.52B | 6.74B | 4.57B | 3.24B |
| Total Equity | 2.56B | 14.15B | 19.12B | 13.85B | 10.9B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.12B | -989M | -2.26B | -3.83B | -3B |
| Investing | 4.21B | 118M | 1.77B | 2.49B | 1.95B |
| Financing | -1.38B | 14M | 48M | 59M | 56M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.03B | 13.62B | 4.98B | -3.12B | -3B |
| Investing | -1.67B | -8.52B | -5.18B | 4.21B | 1.95B |
| Financing | 2.03B | -873M | -3.45B | -1.38B | 56M |
| Market Cap | 11.51B |
| Price to Earnings Ratio | -3.28 |
| Price to Sales Ratio | 3.61 |
| Price to Cash Ratio | 6.06 |
| Price to Book Ratio | 1.07 |
| Dividend Yield | - |
| Shares Outstanding | 385.82M |
| Average Volume (1 week) | 8.66M |
| Average Volume (1 Month) | 12.23M |
| 52 Week Change | -68.49% |
| 52 Week High | 170.47 |
| 52 Week Low | 29.25 |
| Spread (Intraday) | 0.08 (0.27%) |
| Company Name | Moderna Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.modernatx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
